It is a pharma private limited company based in Auroville Post, Tamil Nadu, India, established in 2009.
2009 | Auroville Post, Tamil Nadu, India | ActiveArius Formulations Private Limited, a active private limited company, was established on 05 August 2009 in Auroville Post, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33110TN2009PTC072482. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Employing 14 professional, Its leadership includes Nataraj (Managing Director), Alamelu Nataraj (Director). Past directors included Suresh Thottakat Shankaran, Balasubramanian Anandapadmanaban, Nataraj. It holds ₹3.16 Cr open charges and ₹8.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at R.S. No. 141/1, Plot No. 38 & 47, Navarkulam Main Road, Pattanur, Auroville (Post), Tamil, Nadu, Auroville Post, Tamil Nadu, 605101.
U33110TN2009PTC072482
072482
05 August 2009
₹4.00 M
₹4.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Arius Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nataraj | Managing Director | 05 Aug 2009 | Current |
| Alamelu Nataraj | Director | 05 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Feb 2010 | Past |
| Pramod Abcsdd | Director | 11 Feb 2010 | Past |
| Pramod Abcsdd | Director | 06 Nov 2009 | Past |
| Pramod Abcsdd | Additional Director | 24 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Arius Formulations Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 14.71% decrease. The company also saw a substantial fall in profitability, with a 32.15% decrease in profit. The company's net worth Soared by an impressive increase of 17.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Arius Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹31,601,000.00
₹8,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2023 | Others | ₹3.36 M | Open |
| 03 Oct 2022 | Others | ₹1.66 Cr | Open |
| 20 Mar 2017 | Vijaya Bank | ₹7.00 M | Open |
| 26 Apr 2013 | Vijaya Bank | ₹0.64 M | Open |
| 05 Dec 2009 | Vijaya Bank | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Arius Formulations has a workforce of 14 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Arius Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arius Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Arius Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Arius Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
A charge with Others of Rs. 16.60 M registered on 03 Oct 2022 with Charge ID 100643838 was modified on 01 Sep 2023. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 3.36 M with Charge ID 100788477 was registered on 28 Jun 2023. was documented.
A charge with Others amounted to Rs. 16.60 M with Charge ID 100643838 was registered on 03 Oct 2022. was recorded as a recent event.
Progress on A charge registered on 22 Mar 2017 via Charge ID 100146097 with Vijaya Bank was fully satisfied on 27 May 2022. was documented.
The CIN of Arius Formulations Private Limited is U33110TN2009PTC072482.
Arius Formulations Private Limited is headquartered at R.S. No. 141/1, Plot No. 38 & 47, Navarkulam Main Road, Pattanur, Auroville (Post), Tamil, Nadu, Auroville Post, Tamil Nadu, 605101.
Arius Formulations Private Limited was incorporated on 05 August 2009.
The current directors of Arius Formulations Private Limited are
The primary industry of Arius Formulations Private Limited is Manufacturing.
Arius Formulations Private Limited is unlisted.
The authorized capital of Arius Formulations Private Limited is ₹4.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Arius Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX